Fig. 2.
Characterization of DCs in bone marrow allografts.
(A) Frequencies of cells with phenotypes (1) CD3−, CD4bright, CD8−, low side-scatter, (2) Lin−, CD123bright, HLADR+, CD11c−, and (3) Lin−, CD11c+, HLADR+ were determined by FACS analysis of 29 samples of bone marrow harvested from healthy allogeneic donors. The number of donor cells/kg (×106) in the allograft with phenotype 1 was compared to the numbers of cells with phenotype 2 (○) or 3 (▪). Equations for the best-fit lines comparing the relation between populations 1 and 2 (slope, 1.2; r = 0.92) and between populations 1 and 3 (slope, 2.7; r = 0.85) are shown. (B) Ability of unfractionated bone marrow cells (○) and FACS-isolated CD4+ T-cells (⋄). FACS-isolated CD123− cells (▵) and FACS-isolated Lin−, CD4bright, CD123bright cells (♦) to stimulate proliferation of allogeneic lymphocytes in an MLR was assessed after 5 day co-culture in media containing 10% AB− human serum, 50 ng/mL IL-3, and 100 ng/mL GM-CSF.